{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:35:27Z","timestamp":1758926127353},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T00:00:00Z","timestamp":1280361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00066-010-2132-3","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T23:34:14Z","timestamp":1282952054000},"page":"452-457","source":"Crossref","is-referenced-by-count":16,"title":["Aplastic Anemia as a Cause of Death in a Patient with Glioblastoma Multiforme Treated with Temozolomide"],"prefix":"10.1007","volume":"186","author":[{"given":"Jind\u0159ich","family":"Kopeck\u00fd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Priester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"Slov\u00e1\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Petera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otakar","family":"Kopeck\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Macingova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,29]]},"reference":[{"key":"2132_CR1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1200\/JCO.2005.02.5841","volume":"23","author":"T.J. Doyle","year":"2005","unstructured":"Doyle TJ, Mikkelsen T, Croteau D, et al. Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): report of a phase II trial. ASCO Annual Meeting Proceedings. J Clin Oncol 2005;23:1546.","journal-title":"J Clin Oncol"},{"key":"2132_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00066-009-1965-0","volume":"185","author":"M.G. Fabrini","year":"2009","unstructured":"Fabrini MG, Perrone F, De Franco L, et al. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlenther Onkol 2009;185:524\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2132_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00066-009-1753-x","volume":"185","author":"E. Fokas","year":"2009","unstructured":"Fokas E, Wacker U, Gross MW, et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas. A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009;185:235\u201340.","journal-title":"Strahlenther Onkol"},{"key":"2132_CR4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/SMJ.0b013e3181b1d2fa","volume":"102","author":"B.J. George","year":"2009","unstructured":"George BJ, Eichinger JB, Richard TJ. A rare case of aplastic anemia caused by temozolomide. South Med J 2009;102:974\u20136.","journal-title":"South Med J"},{"key":"2132_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1215\/15228517-2006-024","volume":"9","author":"D.E. Gerber","year":"2007","unstructured":"Gerber DE, Grossman SA, Zeltzman M, et al. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 2007;9:47\u201352.","journal-title":"Neuro Oncol"},{"key":"2132_CR6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"M.E. Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997\u20131003.","journal-title":"N Engl J Med"},{"key":"2132_CR7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00415-002-0839-5","volume":"249","author":"J.J. Heimans","year":"2002","unstructured":"Heimans JJ, Taphoorn MJ. Impact of brain tumour treatment on quality of life. J Neurol 2002;249:955\u201360.","journal-title":"J Neurol"},{"key":"2132_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00066-009-2015-7","volume":"185","author":"G. Iliadis","year":"2009","unstructured":"Iliadis G, Selviaridis P, Kalogera-Fountzila A, et al. The importance of tumor volume in the prognosis of patients with glioblastoma. Comparison of computerized volumetry and geometric models. Strahlenther Onkol 2009;185:743\u201350.","journal-title":"Strahlenther Onkol"},{"key":"2132_CR9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00066-008-1897-0","volume":"184","author":"M. Kocher","year":"2008","unstructured":"Kocher M, Frommolt P, Borberg SK, et al. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol 2008;184:572\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2132_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00066-005-1314-x","volume":"181","author":"M. Kocher","year":"2005","unstructured":"Kocher M, Kunze S, Eich HT, et al. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 2005;181:157\u201363.","journal-title":"Strahlenther Onkol"},{"key":"2132_CR11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-007-9403-6","volume":"85","author":"N. Singhal","year":"2007","unstructured":"Singhal N, Selva-Nayagam S, Brown MP. Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment \u2014 case study and review of literature. J Neurooncol 2007;85:229\u201330.","journal-title":"J Neurooncol"},{"key":"2132_CR12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R. Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"2132_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(04)00680-5","volume":"3","author":"M.J. Taphoorn","year":"2004","unstructured":"Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3:159\u201368.","journal-title":"Lancet Neurol"},{"key":"2132_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-009-9956-7","volume":"96","author":"J.A. Genugten van","year":"2010","unstructured":"van Genugten JA, Leffers P, Baumert BG, et al. Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice. J Neurooncol 2010;96:249\u201357.","journal-title":"J Neurooncol"},{"key":"2132_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(06)70696-9","volume":"7","author":"J.L. Villano","year":"2006","unstructured":"Villano JL, Collins CA, Manasanch EE, et al. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide. Lancet Oncol 2006;7:436\u20138.","journal-title":"Lancet Oncol"},{"key":"2132_CR16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-009-1050-5","volume":"64","author":"J.L. Villano","year":"2009","unstructured":"Villano JL, Seery TE, Bressler LR. Temozolomide in malignant gliomas: current use and future targets. Cancer Chemother Pharmacol 2009;64:647\u201355.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2132-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2132-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2132-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:30:58Z","timestamp":1558564258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2132-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,29]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2132-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,29]]}}}